The Vygon Group welcomes Anne Najaint as CFO

Ecouen, France, February 5, 2018 – Vygon, the single-use medical devices group, today announces the appointment of Anne Najaint as chief financial officer. Her arrival will bolster the group’s senior management.

Ms Najaint, 45, will take over from Bernard Imbert following his retirement at the end 2017. Mr Imbert will stay until March 2018 to assist in the transition.

Anne Najaint will join Vygon’s executive committee and in doing so bring to the decision-making body her vast knowledge and experience. Her main duties will relate to finance, business law and administrative management. This strengthening of expertise forms part of the group’s strategic plan to pursue profitable growth, particularly through the development of international activities. The recent reorganisation of the group into five business units (Intensive Care – Neonatology, Enteral & Obstetrics – Intravascular Therapies – Cardiovascular & Surgery – Anaesthesia & Emergency) will allow the group to more effectively meet customers’ needs and market demands.

“I am delighted to welcome Ms Najaint. Her wealth of experience and expertise will prove invaluable for Vygon,” said Stéphane Regnault, chairman of Vygon’s management board. “I also want to thank Bernard Imbert for his commitment and hard work with Vygon over the last 11 years.”

As a graduate of EM Lyon with more than 20 years of experience in performance management and corporate finance (management control, financial control, financial communication, purchasing, financial and strategic planning), Anne brings world-class expertise in both management and organisation in finance.

Ms Najaint began her career in 1996 working in the banking and industry sectors. In 2011, she joined Stago, an international in-vitro medical diagnostics group, as the financial and strategic planning director. She has always chosen to work for family-run businesses, regardless of whether they are listed on the stock exchange.

About Vygon Group

Vygon designs, manufactures and markets high-tech single-use medical devices for healthcare professionals in hospital and for private and independent practitioners. Vygon is a world leader within this industry, offering a wide range of products in a number of clinical specialties. Organized in five business units (Intensive Care – Neonatology, Enteral & Obstetrics – Intravascular Therapies – Cardiovascular & Surgery – Anesthesia & Emergency), Vygon combines local and international in-depth expertise and know-how in each individual field. With expertise right along the value chain, from product design to the delivery of training for medical personnel, Vygon provides health care professionals with effective and innovative products tailored to their needs and those of their patients, for optimum use and safety. The company distributes over 205 million products a year in more than 120 countries through its network of 27 subsidiaries and 331 distributors. Vygon products display the CE and/or FDA mark and are manufactured in the group’s eight factories in Europe, the USA and Colombia. A family company founded in 1962, Vygon is based in Ecouen, in France’s Greater Paris region. It is a mid-sized business employing 2,150 staff worldwide. The turnover in 2016 was €316 million ($344M), with 81% of this derived from Vygon’s international business.

www.vygon.com